Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, controlled study of KIB-PCI in Japanese healthy adult volunteers
jRCT2080221923Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of KIB-PCI in Influenza A H5N1 infection (H5N1) (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
KIB-PCI
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on jRCT2080221923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221923.